The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use
Event Details
The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.Starting at 9 a.m. ET on December 10th, vaccine experts will review the data supporting Pfizer and BioNTech’s Covid-19 vaccine, all of which is a prelude to the FDA’s decision to grant it an emergency use authorization.